Overview
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 8
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 8, 2021 | Secura Bio Announces Enrollment Completion of the COPIKTRA® (duvelisib) Study (PRIMO) in Peripheral T-cell Lymphoma | |
| Apr 1, 2021 | COPIKTRA® (duvelisib) Receives Positive CHMP Opinion for the Treatment of Relapsed and Refractory CLL and Refractory FL | |
| Feb 2, 2021 | Secura Bio Announces New Data Regarding the Combination of FARYDAK® (panobinostat) with Subcutaneous Bortezomib and Dexamethasone | |
| Mar 6, 2019 | Term Sheet — Wednesday, March 6 | BAD MEDICINE Medicine and money can be a dangerous combination. The rapid rise of health system venture capital funding is surfacing some thorny ethical dilemmas, according to a Healthcare Dive investigation. Paid Content You can't secure w... |
| Mar 6, 2019 | Secura Bio Raises $145M in Financing | Secura Bio, Inc., a Henderson, NV-based integrated biopharmaceutical company dedicated to the worldwide commercialization of significant oncology therapies, closed a $145m equity and debt financing. The round includes: – $55m equity financi... |
| Mar 5, 2019 | Secura Bio Nabs $145M | SAN DIEGO, CA, Secura Bio Inc, a biopharmaceutical company focused on oncology therapies, has raised $145 million in financing. >> Click here for more funding data on Secura Bio >> To export Secura Bio funding data to PDF an... |
| Mar 5, 2019 | Daily funding roundup - March 5th, 2019 | Zabo raised $1.15M; Tagomi raised $12M; RackTop raised $15M; Mocana raised $15M Zabo: Zabo combines your bank with your cryptocurrency. Zabo has raised $1.15 million in funding from Blockchange Ventures. Read more Tagomi: Tagomi combines in... |
Reviews 0
FAQ about Secura Bio, Inc.
When was Secura Bio, Inc. founded?
Secura Bio, Inc. was founded in 2018.
How much funding has Secura Bio, Inc. raised?
Secura Bio, Inc. has raised $145M in total across 1 funding round.
What has the press written about Secura Bio, Inc.?
Parsers VC has collected 8 articles mentioning Secura Bio, Inc., among them “Secura Bio Announces Enrollment Completion of the COPIKTRA® (duvelisib) Study (PRIMO) in Peripheral T-cell Lymphoma” (Apr 8, 2021) and “COPIKTRA® (duvelisib) Receives Positive CHMP Opinion for the Treatment of Relapsed and Refractory CLL and Refractory FL” (Apr 1, 2021).
Is Secura Bio, Inc. still active?
Yes, Secura Bio, Inc. is active; its latest activity on Parsers VC dates from Jun 9, 2021.